Abbonarsi

The progressive application of single-cell RNA sequencing technology in cardiovascular diseases - 10/09/22

Doi : 10.1016/j.biopha.2022.113604 
Yang Ke a, b, 1, Huang Jian-yuan b, h, 1, Zhou Ping g, Wang Yue a, Xing Na b, c, Yang Jian d, Lin Kai-xuan e, f, Sun Yi-fan i, Lin Han-bin b, c, , Li Rong g,
a Zhejiang Provincial Key Laboratory of Biometrology and Inspection and Quarantine, College of Life Science, China Jiliang University, Hangzhou 310018, China 
b Zhongshan Institute for Drug Discovery, SIMM, CAS, Zhongshan 528400, Guangdong, China 
c Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China 
d State Key Laboratory Breeding Base of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China 
e Department of Cardiology, Zhongshan Hospital Affiliated with Guangzhou University of Chinese Medicine (Zhongshan Hospital of Traditional Chinese Medicine), Zhongshan, China 
f Guangzhou University of Chinese Medicine, Guangzhou, China 
g Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, No. 49, Huayuan North Road, Haidian District, Beijing 100191, China 
h School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, China 
i Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing 100020, China 

Corresponding author at: Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.Shanghai Institute of Materia Medica, Chinese Academy of Sciences555 Zu Chong Zhi RoadShanghai201203China⁎⁎Corresponding author.

Abstract

The mortality rate of cardiovascular disease ranks first in the world. Its pathogenesis involves not only internal factors such as immunity, inflammation, metabolic disorders, and self-development but also external factors such as the environment. In the last decade, the emergence of single-cell technology has greatly promoted the development of disease research. Among them, the more mature single-cell RNA sequencing can carry out high-throughput analysis of single cells while studying with single-cell resolution. This technology enables people to characterize the heterogeneity of single cells, identify rare cell types in heart and blood vessels, and construct human heart cell map. With the data analysis of bioinformatics experts, it can also reconstruct the development track of the heart, to construct a map of heart development. Single-cell sequencing plays an important role in analyzing the human physiological structure and disease progression due to its advantages of single-cell resolution. The possibility of combining other omics technologies is proposed by summarizing the existing application examples and advanced technologies like spatial transcriptome. In this review, we summarize the current single-cell sequencing technologies (plate-based and droplet-based) and describe the data analysis process. The latest findings in cardiovascular disease using single-cell RNA sequencing technology are described. Finally, we discussed the shortcomings of single-cell RNA sequencing technology. At the same time, the possibility of the combination of single-cell RNA sequencing and spatial omics technology, and how to apply it to the study of cardiovascular diseases is discussed.

Il testo completo di questo articolo è disponibile in PDF.

Graphical Abstract




ga1

Il testo completo di questo articolo è disponibile in PDF.

Highlights

The manuscript summarizes the current application of single-cell RNA sequencing in cardiovascular disease field.
The process and characteristics of different single-cell RNA sequencing technologies are described. We provides new ideas for developing more high-throughput and low-cost sequencing methods.
It introduces the data analysis process of single-cell RNA sequencing, which provides new thinking for optimizing data processing and improving efficiency.
In order to more conveniently explain the three-dimensional structure changes of tissues and organs in vivo, we discuss the possibility and disadvantages of the combination of single-cell RNA sequencing technology and spatial transcriptome technology.
We introduce the shortcomings and improvement directions of current technologies, and provides new insights for expanding the application scope of single-cell RNA sequencing technology.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : AA, AS, CEL-seq, CPM, CTEPH, CVD, EC, FACS, FRKM, HF, IL, IVT, MA, MI, MMLV-RT, MSC, Nppa, PCR, PLN, pMO, QC, ROS, RPKM, RT, sci-RNA-seq, scRNA-seq, SMC, TNF-α, TS, TSOs, UMAP, UMI, UPR

Keywords : Single-cell analysis, Cardiovascular, Heart diseases, Transcriptomics, Data analysis


Mappa


© 2022  The Authors. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 154

Articolo 113604- ottobre 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • Repurposed itraconazole for use in the treatment of malignancies as a promising therapeutic strategy
  • Chun-Lan Li, Ze-Xuan Fang, Zheng Wu, Yan-Yu Hou, Hua-Tao Wu, Jing Liu
| Articolo seguente Articolo seguente
  • HOTAIR in solid tumors: Emerging mechanisms and clinical strategies
  • Xiangchen An, Yili Liu

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.